In 40 paired clinical specimens from 20 ccRCC patients, MAP2K2 expression was significantly upregulated at the RNA level in cancerous tissues compared to normal renal tissues (Figure 2E). This evidence concerns the gene MAP2K2 and nonpapillary renal cell carcinoma.